skip-to-main

Spikevax XBB.1.5 50 micrograms dispersion for injection in pre-filled syringe

Spikevax® XBB.1.5 is indicated for active immunisation to prevent COVID‑19 caused by SARS-CoV-2 in individuals 12 years of age and older.

Patient Information Leaflet

Summary of Product Characteristics

COVID‑19 Vaccine Moderna

Emergency Use Authorization (EUA) has been granted in the United Arab Emirates for the COVID-19 Vaccine Moderna to prevent COVID-19 in individuals 12 years of age and older.

Patient Information Leaflet

Summary of Product Characteristics

Contact Moderna

    © 2024 Moderna, Inc.

    AE-COV-2100001 09/2024